StockData
Cumberland Pharmaceuticals Inc logo

Cumberland Pharmaceuticals Inc (CPIX) stock

CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 5/3090% above fair value
$6.63+0.51 (+8.33%)

Close on Nov 12, 2026Market cap $99.34MP/E –Yield –

Cumberland Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cumberland Pharmaceuticals's price to sales ratio was 2.9× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.4× to 3.8×, with a median of 0.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.9×+1.0
2025Dec 31, 20251.9×+1.0
2024Dec 31, 20240.9×+0.3
2023Dec 29, 20230.6×−0.1
2022Dec 30, 20220.8×−1.0
2021Dec 31, 20211.8×+0.6
2020Dec 31, 20201.2×−0.8
2019Dec 31, 20192.0×−0.4
2018Dec 31, 20182.4×−0.6
2017Dec 29, 20173.0×+0.2
2016Dec 30, 20162.8×+0.2
2015Dec 31, 20152.6×−0.4
2014Dec 31, 20142.9×+0.4
2013Dec 31, 20132.5×+0.8
2012Dec 31, 20121.7×−0.5
2011Dec 30, 20112.1×−0.4
2010Dec 31, 20102.5×–

More Cumberland Pharmaceuticals figures

See a number that looks wrong?